Log in to save to my catalogue

Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis

Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8762021

Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis

About this item

Full title

Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

Journal title

Annals of the rheumatic diseases, 2022-01, Vol.81 (1), p.124-131

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

More information

Scope and Contents

Contents

ObjectivesGiant cell arteritis (GCA) is the most common primary vasculitis, preferentially affecting the aorta and its large-calibre branches. An imbalance between proinflammatory CD4+ T helper cell subsets and regulatory T cells (Tregs) is thought to be involved in the pathogenesis of GCA and Treg dysfunction has been associated with active diseas...

Alternative Titles

Full title

Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8762021

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8762021

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2021-220955

How to access this item